Howard Flushman
Research Director
Expertise:
With more than 4 decades of experience in healthcare, Howard is recognized for his in-depth knowledge of the complex and shifting specialty market from the manufacturer, payer, and provider perspectives.
He has led the development and release of more than 40 publications on the specialty and biotechnology market, as well as client-specific consulting projects on the management and distribution of specialty and biotechnology products.
In previous roles, Howard was a health plan general manager and network executive, as well as an executive director of multispecialty and single-specialty IPA groups. He has worked with over 20,000 private-practice physicians across all 38 major specialties and all practice organization types.
He began his career managing federal grants and contracts for the UCLA Jonsson Comprehensive Cancer Center.
Howards holds an MPA degree from the University of Southern California, as well as an MBA in marketing/finance and a BA in ancient history from the University of California, Los Angeles.
Articles by Howard Flushman
U.S. physicians disagree with Germany’s determinations of the value of diabetes medicines
According to a recent study from Health Strategies Insights by EVERSANA, 89% of U.S. physicians disagree with Germany’s determinations of the clinical benefit of innovative diabetes medicines. Learn more about our Market Access products & capabilities! Contact us with your questions and data needs, and an expert will follow up shortly.
Ask the Expert – Specialty Pharmacies and Specialty Distributors
According to a recent study from Health Strategies Insights by EVERSANA, 35%-45% of pipeline drugs are infusions and injectables that require nursing services, patient education, cold chain, new reimbursement measures and sites of care. Where is the industry headed? In this issue of Ask the Expert: Specialty Pharmacies, Senior Research Director Howard Flushman shares his insights and […]